HARVARD BIOSCIENCE, INC. (HBIO) Operating Margin
- Operating margin · 12 months: Value -0.28%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -0.28% | Operating income / revenue. Period ending 2026-06-30. $-245.00K ÷ $87.81M × 100 ≈ -0.28% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -245.00K USD | Operating Income (Loss) |
| Revenue | 87.81M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 36.74M USD | Cost of Goods and Services Sold |
| Research and development | 9.09M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-245.00K | $87.81M | $36.74M | $9.09M | (m) | -0.28% |
| 2026-03-31 | $-86.00K | $85.53M | $35.56M | $8.83M | (m) | -0.10% |
| 2025-12-31 | $-48.58M | $86.55M | $36.64M | $8.82M | (m) | -56.13% |
| 2025-09-30 | $-50.28M | $87.37M | $37.62M | $8.97M | (m) | -57.55% |
| 2025-06-30 | $-52.35M | $88.75M | $38.26M | $9.40M | (m) | -58.99% |
| 2025-03-31 | $-53.60M | $91.40M | $39.22M | $9.84M | (m) | -58.65% |
| 2024-12-31 | $-6.21M | $94.14M | $39.37M | $10.41M | (m) | -6.60% |
| 2024-09-30 | $-5.94M | $97.73M | $40.65M | $11.23M | (m) | -6.08% |
| 2024-06-30 | $-5.00M | $101.13M | $42.08M | $11.42M | (m) | -4.94% |
| 2024-03-31 | $-2.13M | $106.79M | $44.29M | $11.75M | (m) | -2.00% |
| 2023-12-31 | $1.89M | $112.25M | $46.18M | $11.76M | (m) | 1.69% |
| 2023-09-30 | $1.16M | $112.52M | $46.95M | $11.46M | (m) | 1.03% |
| 2023-06-30 | $-1.67M | $114.08M | $51.06M | $11.47M | (m) | -1.47% |
| 2023-03-31 | $1.53M | $114.53M | $51.54M | $12.01M | (m) | 1.33% |
| 2022-12-31 | $-6.93M | $113.33M | $52.52M | $12.33M | (m) | -6.12% |
| 2022-09-30 | $-4.78M | $117.96M | $53.42M | $12.43M | (m) | -4.05% |
| 2022-06-30 | $-467.00K | $120.70M | $52.02M | $12.33M | (m) | -0.39% |
| 2022-03-31 | $-4.41M | $120.69M | $52.30M | $11.53M | (m) | -3.65% |
| 2021-12-31 | $2.07M | $118.90M | $51.25M | $10.80M | (m) | 1.74% |
| 2021-09-30 | $3.12M | $116.83M | $51.03M | $10.20M | (m) | 2.67% |
| 2021-06-30 | $2.76M | $111.21M | $48.22M | $9.49M | (m) | 2.48% |
| 2021-03-31 | $3.25M | $105.32M | $44.83M | $8.68M | (m) | 3.09% |
| 2020-12-31 | $221.00K | $102.10M | $44.06M | $8.69M | (m) | 0.22% |
| 2020-09-30 | $-901.00K | $102.09M | $44.52M | $8.98M | (m) | -0.88% |
| 2020-06-30 | $-2.45M | $105.47M | $46.42M | $9.60M | (m) | -2.32% |
| 2020-03-31 | $-2.78M | $111.75M | $50.59M | $10.47M | (m) | -2.48% |
| 2019-12-31 | $377.00K | $116.18M | $51.85M | $10.71M | (m) | 0.32% |
| 2019-09-30 | $485.00K | $119.06M | $53.23M | $11.12M | (m) | 0.41% |
| 2019-06-30 | $2.74M | $120.28M | $53.61M | $11.33M | (m) | 2.28% |
| 2019-03-31 | $2.28M | $122.22M | $56.15M | $11.32M | (m) | 1.87% |
| 2018-12-31 | $984.00K | $120.77M | $57.59M | $10.99M | (m) | 0.81% |
| 2018-09-30 | $150.00K | $133.04M | $69.15M | $9.47M | (m) | 0.11% |
| 2018-06-30 | $-1.13M | $123.12M | $65.55M | $8.22M | (m) | -0.92% |
| 2018-03-31 | $-1.02M | $110.56M | $59.27M | $6.76M | (m) | -0.92% |
| 2017-12-31 | $-101.00K | $101.88M | $54.28M | $5.64M | (m) | -0.10% |
| 2017-09-30 | $-1.90M | $100.83M | $54.30M | $5.28M | (m) | -1.88% |
| 2017-06-30 | $-2.57M | $100.79M | $54.21M | $5.05M | (m) | -2.55% |
| 2017-03-31 | $-3.42M | $101.71M | $54.74M | $5.25M | (m) | -3.36% |
| 2016-12-31 | $-3.00M | $104.52M | $56.11M | $5.39M | (m) | -2.87% |
| 2016-09-30 | $-1.76M | $106.48M | $57.24M | $5.77M | (m) | -1.65% |
| 2016-06-30 | $-1.72M | $107.20M | $57.93M | $5.88M | (m) | -1.61% |
| 2016-03-31 | $-784.00K | $109.86M | $59.67M | $6.10M | (m) | -0.71% |
| 2015-12-31 | $-1.71M | $108.66M | $59.94M | $6.42M | (m) | -1.58% |
| 2015-09-30 | $295.00K | $110.66M | $61.00M | $6.45M | (m) | 0.27% |
| 2015-06-30 | $2.50M | $110.38M | $61.00M | $6.08M | (m) | 2.26% |
| 2015-03-31 | $4.13M | $108.53M | $59.47M | $5.66M | (m) | 3.81% |
| 2014-12-31 | $6.62M | $108.66M | $59.32M | $4.88M | (m) | 6.09% |
| 2014-09-30 | $3.55M | $106.15M | $58.62M | $4.43M | (m) | 3.34% |
| 2014-06-30 | $2.54M | $105.84M | $58.46M | $4.48M | (m) | 2.40% |
| 2014-03-31 | $1.55M | $104.98M | $57.78M | $4.11M | (m) | 1.47% |
| 2013-12-31 | $1.54M | $105.17M | $57.48M | $4.15M | (m) | 1.46% |
| 2013-09-30 | $-1.26M | $105.57M | $56.49M | $7.63M | (m) | -1.20% |
| 2013-06-30 | $-289.00K | $106.53M | $56.77M | $7.55M | (m) | -0.27% |
| 2013-03-31 | $1.78M | $108.94M | $57.65M | $7.55M | (m) | 1.63% |
| 2012-12-31 | $3.17M | $111.17M | $58.75M | $7.32M | (m) | 2.85% |
| 2012-09-30 | $3.84M | $111.95M | $59.71M | $7.04M | (m) | 3.43% |
| 2012-06-30 | $4.13M | $112.23M | $60.11M | $6.73M | (m) | 3.68% |
| 2012-03-31 | $5.36M | $110.87M | $59.58M | $5.88M | (m) | 4.83% |
| 2011-12-31 | $6.08M | $108.86M | $58.60M | $5.43M | (m) | 5.58% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $10.22M | $108.18M | $56.37M | $4.67M | (m) | 9.45% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $8.05M | $85.77M | $44.09M | $4.40M | (m) | 9.39% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |